Amarantus Bioscience Holdings Inc (AMBS)

[GS1]

Which indication you are referring to MANF competition. MANF-RP has ODD status. Is that MANF-PD?

I don't know much about ESS other than prior trials had some safety issues which I think were resolved and my guess is that they are testing it to make sure that is not the case to make it phase II ready. But worldwide market opportunity is lot higher than 700 mil...If there are 1 million people worldwide with burns >30%. It can be game changer..

JN tweeted that there will be two NASDAQ companies listing AMBS therapeutics and diagnostics separately.. That would be awsome if it happens.!